StockNudge

BCRX may start an uptrend

Long
NASDAQ:BCRX   BioCryst Pharmaceuticals, Inc.
After a bit of correction and going down to sub $9 last week, buy side was more powerful Friday afternoon, and the SP climbed above $9.50... $10 is a first level resistance point, but once it is achieved, we can expect the SP to run towards $11.80... Support would be around $8.80 but considering the earnings was moved 2 weeks earlier (which may be a good sign), Factor D news, EU Orladeyo approval and upcoming Q1 earnings, the stock is believed to be in a positive momentum...

My analysis are not investment advice. Always do your own DD and take your own decisions.
Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.